Eva Brun

Medicine & Life Sciences

1. Radiotherapy 100%
2. Squamous Cell Carcinoma of Head and Neck 86%
3. Neoplasms 77%
4. Head and Neck Neoplasms 68%
5. India 64%
6. Positron-Emission Tomography 60%
7. Squamous Cell Carcinoma 56%
8. Fluorodeoxyglucose F18 38%
9. Therapeutics 36%
10. Glucose 33%
11. Pediatrics 33%
12. Drug Therapy 32%
13. Survival 32%
14. Methadone 31%
15. Cisplatin 27%
16. Microvessels 27%
17. Cancer Pain 27%
18. Cancer Care Facilities 25%
19. Uterine Cervical Neoplasms 25%
20. Cetuximab 22%
21. Procedural Pain 22%
22. Spinal Puncture 21%
23. Neck 20%
24. Ketamine 20%
25. Hodgkin Disease 18%
26. Prostate-Specific Antigen 18%
27. Prospective Studies 18%
28. Palliative Care 17%
29. Squamous Cell Neoplasms 17%
30. Cell Line 17%
31. Positron Emission Tomography Computed Tomography 16%
32. Analgesia 16%
33. Recurrence 14%
34. Pain 14%
35. Opioid Analgesics 13%
36. Caregivers 13%
37. Head 13%
38. Chemoradiotherapy 13%
39. Anaplastic Thyroid Carcinoma 12%
40. Terminal Care 12%
41. Quality of Life 12%
42. Oropharyngeal Neoplasms 12%
43. 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose 12%
44. Uterine Neoplasms 11%
45. Metoclopramide 11%
46. Neoplasm Staging 11%
47. Cyclin D1 11%
48. Arsenic 10%
49. Induction Chemotherapy 10%
50. Clinical Studies 10%